Date: 22.9.2014
Technology offer: Vaccinal Nanovector approach for prophylaxis or treatment of an allergy
Reference: 13 FR 34k3 3SOB
Summary: A French research Institute has developed new class of lipid vector for intracellular vaccination using DNA molecule coding for the antigen of asthma. The aim is to produce a prophylactic or therapeutic vaccine. The vaccine administration in animal model led to a reduction of airway hyperresponsiveness and a significant decrease of inflammatory cytokines in the bronchoalveolar lavage. Industrial partners are sought in order to co-develop asthma and rhinitis allergy applications.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology portal - at Wikipedia. Useful information for you.
Massachusetts institute of technology - University
Antarctic bacteria show promise as biocontrol agents for combating banana wilt
CRISPR/Cas9 modifies Euglena to create potential biofuel source